Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for CDNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 373.64M
March 31, 2026 187.18M
December 31, 2025 177.21M
September 30, 2025 194.22M
June 30, 2025 186.26M
March 31, 2025 230.92M
December 31, 2024 260.65M
September 30, 2024 240.85M
June 30, 2024 228.87M
March 31, 2024 215.92M
December 31, 2023 235.42M
September 30, 2023 268.18M
June 30, 2023 282.67M
March 31, 2023 285.94M
December 31, 2022 293.09M
September 30, 2022 291.28M
June 30, 2022 306.22M
March 31, 2022 319.22M
December 31, 2021 348.48M
September 30, 2021 363.28M
June 30, 2021 369.94M
March 31, 2021 374.29M
December 31, 2020 224.70M
September 30, 2020 213.80M
June 30, 2020 211.41M
Date Value
March 31, 2020 32.19M
December 31, 2019 38.22M
September 30, 2019 40.93M
June 30, 2019 43.47M
March 31, 2019 57.43M
December 31, 2018 64.62M
September 30, 2018 26.20M
June 30, 2018 16.25M
March 31, 2018 18.70M
December 31, 2017 16.90M
September 30, 2017 5.976M
June 30, 2017 9.104M
March 31, 2017 12.19M
December 31, 2016 17.26M
September 30, 2016 22.26M
June 30, 2016 17.14M
March 31, 2016 23.75M
December 31, 2015 29.89M
September 30, 2015 33.95M
June 30, 2015 36.89M
March 31, 2015 38.98M
December 31, 2014 36.43M
September 30, 2014 39.05M
June 30, 2014 7.872M
March 31, 2014 4.837M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Natera, Inc. 1.092B
Caris Life Sciences, Inc. 793.12M
Myriad Genetics, Inc. 115.20M
BioRestorative Therapies, Inc. 3.592M
Exagen, Inc. 24.59M